This new 73-country survey from LeadingMarketResearch.com provides granular data and analysis not available from any other source.
The report is designed to help current suppliers and potential market entrants identify and evaluate major business opportunities emerging in the stool diagnostic testing market during the next five years. The report is available by section, and can be customized to specific information needs and budget.
To fit your research budget and receive sections of this report or specific data on geographic regions, countries, markets, companies, technologies and products, select the exact information you need from our In Vitro Diagnostics Database.
Highlights
- Supplier market shares in Europe, Latin America, Middle East, and North America
- Five-year test volume and sales forecasts
- Strategic profiles of market players and start-up firms developing innovative technologies and products
- Emerging technologies
- Review of molecular diagnostic analyzers
- Specific product and business opportunities for instrument and consumable suppliers
Geographic Regions and Countries
Europe
Albania, Austria, Belarus, Belgium, Bulgaria, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Georgia, Germany, Greece, Hungary, Iceland, Ireland, Italy, Kazakhstan, Latvia, Lithuania, Malta, Moldova, Netherlands, Norway, Poland, Portugal, Romania, Russia, Serbia, Slovakia, Slovenia, Spain, Sweden, Switzerland, UK, Ukraine
Latin America
Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Cuba, Dominican Republic, Ecuador, El Salvador, Guatemala, Haiti, Honduras, Jamaica, Mexico, Nicaragua, Panama, Paraguay, Peru, Puerto Rico, Uruguay, Venezuela
Middle East
Bahrain, Iran, Iraq, Israel, Jordan, Kuwait, Lebanon, Oman, Qatar, Saudi Arabia, United Arab Emirates
North America
Canada, Mexico, USA
Market Segmentation Analysis
Market shares of key suppliers of stool diagnostic tests in major geographic regions.
Five-year test volume and sales forecasts for major tests, including:
Adenovirus
Calprotectin
Campylobacter
Clostridium difficil GDH
Clostridium Toxins A and B
Colon-Specific Antigen
E. Coli
Elastase
Enterohemorrhagic E. coli toxins
Enterovirus
Helicobacter Pylori
Occult Blood
Rotavirus
Shigella
Competitive Assessments
- Extensive strategic assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, collaborative arrangements and new technologies/products in R&D.
- Companies developing and marketing stool diagnostic products.
Opportunities and Strategic Recommendations
- Specific new product development opportunities with potentially significant market appeal during the next five years.
- Design criteria for new products.
- Alternative market penetration strategies.
- Potential market entry barriers and risks.
- Business planning issues and concerns.
